We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-19.74%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$2B
AUM Growth
+$181M
Cap. Flow
-$182M
Cap. Flow %
-9.13%
Top 10 Hldgs %
62.34%
Holding
416
New
102
Increased
87
Reduced
79
Closed
120

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$21.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$21.2M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.1M
4
BIIB icon
Biogen
BIIB
+$9.79M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$8.84M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$33.1M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$7.45M
3
MBLY
Mobileye N.V.
MBLY
+$7.26M
4
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$5.86M
5
ASXC
Asensus Surgical, Inc.
ASXC
+$5.01M

Sector Composition

Rank Sector Weight
1 Healthcare 11.94%
2 Consumer Staples 0.06%
3 Industrials 0.04%
4 Technology 0.04%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KERX
376
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-158
Closed -$80K
KITE
377
DELISTED
Kite Pharma, Inc.
KITE
– –
-16,571
Closed -$803K
KITE
378
PUT
DELISTED
Kite Pharma, Inc.
KITE
– –
-808
Closed -$4.98M
MBLY
379
CALL
DELISTED
Mobileye N.V.
MBLY
– –
-461
Closed -$1.95M
MBLY
380
DELISTED
Mobileye N.V.
MBLY
– –
-171,672
Closed -$7.26M
MBLY
381
PUT
DELISTED
Mobileye N.V.
MBLY
– –
-2,011
Closed -$8.5M
TROVW
382
CALL
DELISTED
TrovaGene, Inc. Warrant
TROVW
– –
-2,600
Closed -$1.4M
ZLTQ
383
CALL
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-610
Closed -$1.74M
ROSG
384
DELISTED
Rosetta Genomics Ltd.
ROSG
– –
-13,246
Closed -$196K
VASC
385
DELISTED
Vascular Solutions Inc
VASC
– –
-30,626
Closed -$1.05M
VASC
386
PUT
DELISTED
Vascular Solutions Inc
VASC
– –
-623
Closed -$2.14M
HTWR
387
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-19,900
Closed -$1M
HTWR
388
PUT
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-199
Closed -$1M
BITI
389
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
– –
-50,460
Closed -$714K
SUNE
390
CALL
DELISTED
SUNEDISON, INC COM
SUNE
– –
-1,000
Closed -$509K
REE
391
DELISTED
RARE ELEMENT RES LTD
REE
– –
-3,436,858
Closed -$519K
OCAT
392
PUT
DELISTED
OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
– –
-624
Closed -$525K
POZN
393
DELISTED
POZEN INC
POZN
– –
-199,800
Closed -$1.36M
VPCO
394
DELISTED
VAPOR CORP DEL COM STK
VPCO
– –
-901,608
Closed -$487K
PRSN
395
DELISTED
PERSEON CORP COM STK NEW (DE)
PRSN
– –
-16,451
Closed -$4K
CTIC
396
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-575
Closed -$707K
CTIC
397
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-57,567
Closed -$708K
BDSI
398
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-1,800
Closed -$862K
CHL
399
CALL
DELISTED
China Mobile Limited
CHL
– –
-481
Closed -$2.71M
NDRM
400
PUT
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-651
Closed -$1.11M
13 14 15
16
17

Similar funds

NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Sabby Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sabby Management held 416 positions worth $2B, up 9.9% from $1.82B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sabby Management withdrew a net $182M in Q1 2016, closing 120 positions and reducing 79 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $33.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Sabby Management opened a new position in Amgen worth $21.5M.

  • Sabby Management's largest Q1 2016 buy was Amgen: 143,486 shares worth $21.5M.
  • Sabby Management added most to Northwest Biotherapeutics, Inc. Common stock in Q1 2016, an estimated $4.73M increase.
  • Sabby Management's biggest Q1 2016 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $7.45M.
  • Sabby Management fully exited iShares Russell 2000 ETF in Q1 2016, selling an estimated $33.1M.
  • Sabby Management's ten largest holdings make up 62% of its $2B portfolio in Q1 2016.
  • Sabby Management opened 102 new positions and closed 120 in Q1 2016.
  • Sabby Management's portfolio value rose 9.9% quarter-over-quarter to $2B.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.